Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$10.77 USD
-0.27 (-2.45%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $10.78 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OFIX 10.77 -0.27(-2.45%)
Will OFIX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OFIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OFIX
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates
OFIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings
Orthofix (OFIX) Q4 Earnings Lag Estimates
Orthofix (OFIX) Q3 Earnings Surpass Estimates
Other News for OFIX
Rewey Asset Management Q2 2025 Investment Letter
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference | OFIX Stock News
Orthofix to Report Second Quarter 2025 Financial Results | OFIX Stock News
Orthofix (OFIX) Receives Outperform Rating with Promising Growth Outlook | OFIX Stock News
Orthofix initiated with an Outperform at Barrington